Can eye tracking plus deep learning flag Alzheimer’s?
On a 210-person 3D visuospatial eye-tracking set, a nested-autoencoder model reached 85% average accuracy distinguishing AD from healthy controls.
Source
A novel deep learning approach for diagnosing Alzheimer's disease based on eye-tracking data
What they did
Built a 3D visuospatial memory task, recorded eye movements from 108 AD patients and 102 controls, extracted fixation heatmaps, and trained a nested autoencoder with adaptive feature fusion, comparing against traditional ML and typical DL models via four-fold CV (plus ablations).
What they found
The proposed network averaged 85% AD-recognition accuracy and beat the comparison ML/DL baselines on the same eye-tracking dataset.
The limits
What it doesn't show
Single-center Chinese clinic sample; 85% is cross-validated accuracy, not a deployed screening claim, and does not replace clinical diagnosis.
Key terms
- Eye-tracking
- Recording gaze to infer attention/memory during visual tasks.
- Fixation heatmap
- Spatial map of where participants look during a trial.
- Nested autoencoder
- Stacked encoder–decoder used here to extract gaze features.
- PwAD / HC
- Patients with Alzheimer’s disease vs healthy controls.
- Four-fold CV
- Cross-validation scheme used to estimate average accuracy.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
How many AD patients were recruited?
Common questions
Sample size?
108 AD + 102 healthy controls.
Reported accuracy?
85% average under four-fold CV.
Task type?
3D visuospatial memory with recorded eye movements.
Core model piece?
Nested autoencoder on fixation heatmaps plus adaptive fusion.